News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Larson Yi
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 325,901 shares
@ $0 |
|
| 01/24/2023 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 464,099 options to buy
@ $2.66, valued at
$1.2M
|
|
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 5,996 options to buy
@ $16, valued at
$95.9k
|
|
| 11/01/2021 |
4
| Larson Yi (CFO) has filed a Form 4 on LianBio|
Txns:
| Granted 229,538 options to buy
@ $16, valued at
$3.7M
|
|
| 10/29/2021 |
3
| Larson Yi (CFO) has filed a Form 3 on LianBio |
| 06/10/2021 |
4
| Larson Yi (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $27.66, valued at
$595.2k
|
|
| 04/06/2021 |
4
| Larson Yi (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $34.8, valued at
$748.9k
Granted 3,773 options to buy
@ $34.8, valued at
$131.3k
|
|
| 04/06/2021 |
3
| Larson Yi (Director) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 02/02/2021 |
4
| Larson Yi (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 4,783 shares
@ $122.94, valued at
$588k
Sold 8,576 shares
@ $123.7, valued at
$1.1M
Sold 2,143 shares
@ $124.6, valued at
$267k
Sold 200 shares
@ $126.07, valued at
$25.2k
Sold 1,000 shares
@ $127.58, valued at
$127.6k
Sold 400 shares
@ $128.41, valued at
$51.4k
Sold 4,574 shares
@ $129.8, valued at
$593.7k
Sold 7,267 shares
@ $130.58, valued at
$948.9k
Sold 1,057 shares
@ $131.73, valued at
$139.2k
Exercised 15,702 options to buy
@ $54.03, valued at
$848.4k
Exercised 14,298 options to buy
@ $54.03, valued at
$772.5k
|
|
| 01/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| Larson Yi (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 312,397 options to buy
@ $54.03, valued at
$16.9M
|
|
| 08/27/2019 |
3
| Larson Yi (EVP & CFO) has filed a Form 3 on Turning Point Therapeutics, Inc. |
|
|